Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing | News
Search Refinements

Manufacturing News

View news from other Pharmaceutical sectors:
76-90 of 2230 results
Intas to buy Actavis UK and Ireland business form Teva
By PBR Staff Writer
Indian drugmaker Intas Pharmaceuticals has agreed to acquire Actavis Generics’ assets and operations in the UK and Ireland from Teva Pharmaceutical Industries for about £603m.
Production & Manufacturing > Manufacturing > News
Depomed gets favorable patent ruling in US for NUCYNTA ANDAs
Judge Claire C. Cecchi of the United States District Court for the District of New Jersey has ruled in favor of Depomed in the company's patent litigation against all three filers of Abbreviated New Drug Applications (ANDAs) for Depomed's NUCYNTA franchise.
Production & Manufacturing > Manufacturing > News
Novo Nordisk plans to cut 1,000 jobs amid increasing competition
By PBR Staff Writer
Danish drug maker Novo Nordisk is planning to lay off about 1,000 employees globally in order to reduce operating costs.
Production & Manufacturing > Manufacturing > News
Pfizer scraps plan to split into two companies
By PBR Staff Writer
Pfizer said it would remain a single company, deciding not to split its branded drugs and generics businesses into two stand-alone firms.
Production & Manufacturing > Manufacturing > News
Pharmaron enters into non-binding heads of terms with MSD over Hoddesdon UK site
Pharmaron has entered into a non-binding Heads of Terms (HoTs) with Merck Sharp & Dohme Limited (MSD) for the sale of the Hoddesdon UK site which includes MSD’s process development and research facility.
Production & Manufacturing > Manufacturing > News
GSK names Emma Walmsley as new CEO
GlaxoSmithKline (GSK) has named Emma Walmsley as its new chief executive officer (CEO).
Production & Manufacturing > Manufacturing > News
Sanofi files patent infringement suit against Merck
By PBR Staff Writer
French pharmaceutical firm Sanofi has filed a lawsuit against Merck’s international unit over alleged patent infringements.
Production & Manufacturing > Manufacturing > News
Horizon Discovery licenses biomanufacturing Cell Lines to CPI and NIBRT
Horizon Discovery Group has formed new partnerships with both the Centre for Process Innovation (CPI) and the National Institute for Bioprocessing Research and Training (NIBRT) to support biologic therapeutic manufacturing in the UK, Ireland and beyond.
Production & Manufacturing > Manufacturing > News
Thermo Fisher Scientific opens new clinical services facility in South Korea
Thermo Fisher Scientific has opened a new GMP standard facility in South Korea to address the growing global demand for clinical services.
Production & Manufacturing > Manufacturing > News
Avara to buy AstraZeneca's UK manufacturing facility
Avara Pharmaceutical Services has agreed to acquire AstraZeneca's manufacturing facility located in Avlon, Avonmouth, England, UK.
Production & Manufacturing > Manufacturing > News
Galenica completes acquisition of Relypsa
Galenica Group announced the completion of its previously announced acquisition of Relypsa.
Production & Manufacturing > Manufacturing > News
Allergan and Adamas settle NAMZARIC patent litigation with Amneal
Allergan announced that its subsidiaries Forest Laboratories LLC, Forest Laboratories Holdings, Ltd. and Allergan USA, along with Adamas Pharmaceuticals, have entered into a settlement agreement with Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York, LLC.
Production & Manufacturing > Manufacturing > News
BioInvent extends manufacturing services contract with global pharmaceutical client
BioInvent International has signed an extended contract for manufacturing services with one of its current customers, a major global pharmaceutical client.
Production & Manufacturing > Manufacturing > News
AstraZeneca to sell part of antibiotics business to Pfizer in $1.6bn deal
By PBR Staff Writer
AstraZeneca has agreed to sell part of its antibiotics business to Pfizer in a deal worth about $1.6bn.
Production & Manufacturing > Manufacturing > News
Fresenius Kabi to invest $250m to expand pharmaceutical manufacturing facility in US
By PBR Staff Writer
Health care firm Fresenius Kabi is set to invest around $250m to expand its pharmaceutical manufacturing facility in Melrose Park, Illinois, US.
Production & Manufacturing > Manufacturing > News
76-90 of 2230 results